Update Großgefäßvaskulitis 2021

 

 Buy Article Permissions and Reprints

Was ist neu?

Klinischer Zugang Die Bestimmung der Prätestwahrscheinlichkeit auf Basis standardisierter Scoring-Systeme kann die Testgüte bildgebender Verfahren in der Diagnostik der Riesenzellarteriitis erhöhen.

Bildgebende Diagnostik Die hochauflösende Sonografie der Gefäßwand ist das Erstlinienverfahren in der Riesenzellarteriitis-Diagnostik, falsch positive Befunde können jedoch bei kardiovaskulärem Risikoprofil, insbesondere bei Männern jenseits des 70. Lebensjahres, vorkommen.

Therapiekontrolle In der Therapiekontrolle ist Bildgebung unverzichtbar. Die PET-CT ist hier am besten untersucht, jedoch verbleiben Unklarheiten bezüglich der Befundinterpretation. Eine wertvolle alternative bzw. ergänzende Methode stellt die Kontrastmittelsonografie dar.

Abstract

In recent years, clinically significant advances have been made in the management of giant cell arteritis and Takayasu arteritis. This concise review article highlights important aspects of the diagnostic workup and imaging-based treatment surveillance of the large vessel vasculitides.

Publication History

Article published online:
26 November 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• Literatur

• 1 Schirmer JH, Aries PM, Balzer K. et al. [S2k guidelines: management of large-vessel vasculitis]. Z Rheumatol 2020; 79 (Suppl. 03) 67-95
  CrossrefPubMedGoogle Scholar
• 2 Sebastian A, Tomelleri A, Kayani A. et al. Probability-based algorithm using ultrasound and additional tests for suspected GCA in a fast-track clinic. RMD open 2020; 6 (03) e001297
  CrossrefPubMedGoogle Scholar
• 3 Czihal M, Lottspeich C, Bernau C. et al A diagnostic algorithm based on a simple clinical prediction rule for the diagnosis of cranial giant cell arteritis. J Clin Med 2021; DOI: 10.3390/jcm10061163.
  CrossrefPubMedGoogle Scholar
• 4 Junek M, Hu A, Garner S. et al. Contextualizing temporal arterial magnetic resonance angiography in the diagnosis of giant cell arteritis: a retrospective cohort study. Rheumatology (Oxford) 2021; DOI: 10.1093/rheumatology/keaa916.
  CrossrefPubMedGoogle Scholar
• 5 Danda D, Goel R, Joseph G. et al. Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease. Rheumatology (Oxford, England) 2021; 60: 2246-2255
  CrossrefPubMedGoogle Scholar
• 6 Ješe R, Rotar Ž, Tomšič M. et al. The cut-off values for the intima-media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteries. Rheumatology (Oxford) 2021; DOI: 10.1093/rheumatology/keaa578.
  CrossrefPubMedGoogle Scholar
• 7 Martire MV, Cipolletta E, Matteo AD. et al. Is the intima-media thickness of temporal and axillary arteries influenced by cardiovascular risk?. Rheumatology (Oxford) 2021; DOI: 10.1093/rheumatology/keab117.
  CrossrefPubMedGoogle Scholar
• 8 Czihal M, Köhler A, Lottspeich C. et al. Temporal artery compression sonography for the diagnosis of giant cell arteritis in elderly patients with acute ocular arterial occlusions. Rheumatology (Oxford) 2020; 60: 2190-2196
  CrossrefPubMedGoogle Scholar
• 9 Hop H, Mulder DJ, Sandovici M. et al. Diagnostic value of axillary artery ultrasound in patients with suspected giant cell arteritis. Rheumatology (Oxford) 2020; 59: 3676-3684
  CrossrefPubMedGoogle Scholar
• 10 Imfeld S, Aschwanden M, Rottenburger C. et al. [¹⁸F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?. Rheumatology (Oxford) 2020; 59: 772-778
  CrossrefPubMedGoogle Scholar
• 11 Nienhuis PH, Sandovici M, Glaudemans AW. et al. Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis. Semin Arthritis Rheum 2020; 50: 616-623
  CrossrefPubMedGoogle Scholar
• 12 Singh V, Naik S, Robert J. et al. Endovascular biopsy in Takayasu arteritis. Eur J Rheumatol 2019; 6: 155-157
  CrossrefPubMedGoogle Scholar
• 13 Quinn KA, Dashora H, Novakovich E. et al. Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis. Rheumatology (Oxford, England) 2020; DOI: 10.1093/rheumatology/keaa894.
  CrossrefPubMedGoogle Scholar
• 14 Quinn KA, Rosenblum JS, Rimland CA. et al. Imaging acquisition technique influences interpretation of positron emission tomography vascular activity in large-vessel vasculitis. Semin Arthritis Rheum 2020; 50: 71-76
  CrossrefPubMedGoogle Scholar
• 15 Lottspeich C, Dechant C, Köhler A. et al. Assessment of Disease Activity in Takayasu Arteritis: Potential Role of Contrast-Enhanced Ultrasound. Ultraschall in Med 2019; 40: 638-645
  Article in Thieme ConnectPubMedGoogle Scholar